Methylxanthines
Mechanism :
blocks actions of phosphodiesterase and
adenosine / increases cAMP levels due to decreased cAMP hydrolysis
Effects:
bronchodilator, antinflammatory, bronchoprotective
positive cardiac inotropic effects, produces vasodilation, has diuretic action and stimulates diaphragmatic contraction
Use :
for maintenance therapy in patient with moderate to severe asthma / usage is limited because of narrow therapeutic index (cardiotoxicity, neurotoxicity)
Side Effects :
capable of causing nausea, insomnia
Acute toxicity :
vomitin, abdominal pain, seizures and cardiac arrhythmias
seizures most common cause of morbidity and mortality, followed by tachyarrhythmia but does not cause QT-prolongation
- beta-blocker are drug of choice for theophylline induced tachyarrhythmias
- seizures are difficult to treat but use benzo and barbiturates
Clearance :
metabolized by cytochrome P450
varies with age (highest in young adolescents) ; half life in children is less because of faster hepatic metabolism
smoking status (higher in smokers)
concurrent use of other drugs that inhibit or induce hepatic enzymes